PHF6和RUNX1突变合作加速白血病发生
Yueh-Chwen Hsu1, Chi-Yuan Yao2, Chang-Tsu Yuan3
1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Translational oncology
|June 27, 2025
概括
在RUNX1和PHF6 (植物主体指基因6) 中的突变协同驱动急性髓性白血病 (AML) 的发展. 这项研究揭示了它们的关节病理影响,并确定了关键的分子机制,包括多能原始体中的Hmga2上调.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- RUNX1是血液形成中的关键转录因子,其突变与血液学疾病有关.
- 作为一种表观遗传修饰剂的PHF6也具有与骨髓性和淋巴性白血病相关的突变.
- 之前的研究表明RUNX1和PHF6突变之间存在积极的关联,但它们的联合病理影响是未知的.
研究的目的:
- 调查RUNX1和PHF6突变之间的关联的病理基础.
- 分析患有这些突变的急性髓性白血病 (AML) 患者的临床,遗传和转录特征.
- 使用小鼠模型探索RUNX1和PHF6突变组合的体内效应.
主要方法:
- 来自1188名成年AML患者的临床,遗传和转录组数据的分析.
- 一个具有RUNX1和Phf6突变组合的小鼠模型的生成.
- 在体内移植实验中,使用来自突变小鼠的骨髓细胞.
主要成果:
- 在AML患者中观察到PHF6和RUNX1突变的频繁同时发生,与更差的临床结果相关.
- 双重突变细胞在体内显示出增强的白血病发生特征和更高的移植能力,导致更短的生存期.
- 多能原始细胞 (MPPs) 被确定为关键细胞类型,高调的Hmga2有助于双变异MPPs的自我更新.
结论:
- 在体内,RUNX1和PHF6突变表现出协同性的白血病发生潜力.
- 这项研究提供了对这种高风险AML亚型的病原体的分子洞察力.
- 在MPP中Hmga2的升级是驱动双变异AML白血病发生的关键机制.
相关概念视频
02:38The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.0K
01:24Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:39Mutations
84.6K
Overview
84.6K